OBGYN.net Conference CoverageFrom ISGE 2001 Congress - Chicago, Illinois, 2001
Click here for Audio/Video Version *requires RealPlayer - free download
Dr. Yap Lip Kee: “I’m Dr. Yap Lip Kee the incoming President for the ISGE. It’s a pleasure to be here in Chicago. We are looking at the newest things available to gynecologists, gynecology, and endoscopists. With me is Dr. James Daniell, one of the pioneers in the field and he plans to tell us a bit more about what is new.”
Dr. James Daniell: “Dr. Yap, thank you very much. It’s always a pleasure to get the chance to be interviewed for OBGYN.net because it gives a wide dissemination of information around the world. The things that I’ve seen from walking around the exhibits here today are interesting. There’s some old, there’s some new, there’s some borrowed, but there’s nothing blue here today. I think we’ve got about thirty-five exhibitors from many countries. One of the things that I saw that is most interesting is a new safer way to use bipolar electro-surgery. Everest Medical, which is located here in the states, is coming out with a new generator from England, which allows laparoscopic use of bipolar instrumentation with a system of bipolar that they call “PK” generation. This is really just bipolar energy delivered in an intermittent pulse mode so that there’s reduced thermo damage as your applying the electrosurgery. As you and I both know with laparoscopy, electricity can be very, very dangerous and anything that can reduce the risk for collateral damage with electricity, I think, will be a benefit for improved safety of surgery. We’ve also done some animal studies with this PK generator in our lab in Nashville, and we’ve been able to actually coagulate blood vessels as large as 5 mm laparoscopically in animal model, which I think is very impressive. I think this is one of the things at this meeting here of the ISGE that is very impressive in just coming on market here in the states and will be a good addition to the armamentarium for all laparoscopic surgeons that are dealing with large blood vessels during either hysterectomy or adnexal removal. Again, it’s my pleasure to sit and talk with you here briefly and to talk about this for OBGYN.net. Thank you.”
Dr. Yap Lip Kee: “Thank you, Jim, for the quick updates.”
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More